120 related articles for article (PubMed ID: 25912745)
1. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer.
Hamai Y; Hihara J; Emi M; Murakami Y; Kenjo M; Nagata Y; Okada M
Ann Thorac Surg; 2015 Jun; 99(6):1887-93. PubMed ID: 25912745
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis.
Pucher PH; Rahman SA; Walker RC; Grace BL; Bateman A; Iveson T; Jackson A; Rees C; Byrne JP; Kelly JJ; Noble F; Underwood TJ
Eur J Surg Oncol; 2020 Dec; 46(12):2248-2256. PubMed ID: 32694054
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051).
Lockhart AC; Reed CE; Decker PA; Meyers BF; Ferguson MK; Oeltjen AR; Putnam JB; Cassivi SD; Montero AJ; Schefter TE;
Ann Oncol; 2014 May; 25(5):1039-44. PubMed ID: 24562448
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network.
Tankel J; Ahmed N; Mueller C; Najmeh S; Spicer J; Mulder D; Cool-Lartigue J; Rousseau M; Frechette D; Sud S; Kavan P; Moghrabi A; Champagne M; Lemay F; Dalfen R; Sirhan S; Asselah J; Alcindor T; Ferri L
Ann Surg Oncol; 2024 Apr; 31(4):2461-2469. PubMed ID: 38142255
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer.
Cooper L; Dezube AR; De León LE; Kucukak S; Mazzola E; Dumontier C; Mamon H; Enzinger P; Jaklitsch MT; Frain LN; Wee JO
Eur J Surg Oncol; 2021 Oct; 47(10):2667-2674. PubMed ID: 33895020
[TBL] [Abstract][Full Text] [Related]
6. Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma.
McKay SC; Louie BE; Molena D; Andrews WG; Boerner T; Hofstetter WL; Yeung J; Darling GE; Sharata A; Peyre CG; Dunn C; Lipham JC; Marginean H; DeMeester SR
J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1943-1950. PubMed ID: 37788788
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Pneumonia is Associated with Long-Term Oncologic Outcomes of Definitive Chemoradiotherapy Followed by Salvage Esophagectomy for Esophageal Cancer.
Takeuchi M; Kawakubo H; Mayanagi S; Yoshida K; Fukuda K; Nakamura R; Suda K; Wada N; Takeuchi H; Kitagawa Y
J Gastrointest Surg; 2018 Nov; 22(11):1881-1889. PubMed ID: 29980971
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Esophageal Carcinoma with Tracheal Invasion after Preoperative Treatment with Docetaxel, Cisplatin, and 5-Fluorouracil in Which Definitive Chemoradiotherapy and Salvage Esophagectomy Prolonged Survival].
Sakakibara K; Ichikawa H; Kano Y; Muneoka Y; Usui K; Moro K; Tsuchida J; Yuki H; Miura K; Tajima Y; Nakano M; Takizawa K; Shimada Y; Sakata J; Waka T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1447-1449. PubMed ID: 38303303
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in multidisciplinary treatment for patients with esophageal cancer.
Watanabe M; Otake R; Kozuki R; Toihata T; Takahashi K; Okamura A; Imamura Y
Surg Today; 2020 Jan; 50(1):12-20. PubMed ID: 31535225
[TBL] [Abstract][Full Text] [Related]
10. The amount of neoadjuvant chemotherapy for Barrett's carcinoma does not correlate with long-term survival.
Schauer M; Knoefel WT; Friess H; Theisen J
J Gastrointest Surg; 2011 Oct; 15(10):1750-5. PubMed ID: 21811882
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan.
Okumura H; Mori N; Tanaka T; Morita M; Toh Y; Saeki H; Maehara Y; Nakamura K; Honda H; Yoshida N; Baba H; Natsugoe S
Dis Esophagus; 2016 Nov; 29(8):1135-1143. PubMed ID: 26542524
[TBL] [Abstract][Full Text] [Related]
12. A Phase II Study of Neoadjuvant Chemoradiotherapy with Docetaxel, Cisplatin and 5-FU Followed by Surgical Resection in the Treatment of Locally Advanced Esophagogastric Junction Cancer and Locally Advanced Esophageal Cancer.
Chen CC; Yeh HL; Chuang CY; Hsu CP
Clin Pract; 2024 Apr; 14(2):642-652. PubMed ID: 38666809
[TBL] [Abstract][Full Text] [Related]
13. Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis.
Lee Y; Samarasinghe Y; Lee MH; Thiru L; Shargall Y; Finley C; Hanna W; Levine O; Juergens R; Agzarian J
Ann Surg; 2022 Jan; 275(1):91-98. PubMed ID: 34596073
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for Resectable Locally Advanced Esophageal Carcinoma.
Fick CN; Dunne EG; Sihag S; Molena D; Cytryn SL; Janjigian YY; Wu AJ; Worrell SG; Hofstetter WL; Jones DR; Gray KD
Ann Thorac Surg; 2024 Jul; 118(1):130-140. PubMed ID: 38408631
[TBL] [Abstract][Full Text] [Related]
15. Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.
Shaikh T; Ruth K; Scott WJ; Burtness BA; Cohen SJ; Konski AA; Cooper HS; Astsaturov I; Meyer JE
Ann Thorac Surg; 2015 Jan; 99(1):270-6. PubMed ID: 25440267
[TBL] [Abstract][Full Text] [Related]
16. Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study.
Chidambaram S; Owen R; Sgromo B; Chmura M; Kisiel A; Evans R; Griffiths EA; Castoro C; Gronnier C; MaoAwyes MA; Gutschow CA; Piessen G; Degisors S; Alvieri R; Feldman H; Capovilla G; Grimminger PP; Han S; Low DE; Moore J; Gossage J; Voeten D; Gisbertz SS; Ruurda J; van Hillegersberg R; D'Journo XB; Chmelo J; Phillips AW; Rosati R; Hanna GB; Maynard N; Hofstetter W; Ferri L; Berge Henegouwen MI; Markar SR
Ann Surg; 2023 Nov; 278(5):701-708. PubMed ID: 37477039
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer.
Mayanagi S; Irino T; Kawakubo H; Kitagawa Y
Ann Gastroenterol Surg; 2019 May; 3(3):269-275. PubMed ID: 31131355
[TBL] [Abstract][Full Text] [Related]
18. Real-World Experience of Patient's Compliance and Clinical Outcomes for Trimodality Treatment for Esophageal Cancer: a Study from a Cancer Center in North-East India.
Das G; Arun PS; Roy PS; Sarma G; Nath J; Kalita DJ; Talukdar A
Indian J Surg Oncol; 2024 Jun; 15(2):241-249. PubMed ID: 38741641
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis.
van der Wilk BJ; Eyck BM; Hofstetter WL; Ajani JA; Piessen G; Castoro C; Alfieri R; Kim JH; Kim SB; Furlong H; Walsh TN; Nieboer D; Wijnhoven BPL; Lagarde SM; Lanschot JJBV
Ann Surg; 2022 Mar; 275(3):467-476. PubMed ID: 34191461
[TBL] [Abstract][Full Text] [Related]
20. Treatment of thoracic esophageal carcinoma invading adjacent structures.
Seto Y; Chin K; Gomi K; Kozuka T; Fukuda T; Yamada K; Matsubara T; Tokunaga M; Kato Y; Yafune A; Yamaguchi T
Cancer Sci; 2007 Jul; 98(7):937-42. PubMed ID: 17441965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
